EichorEICHOR
Study identifier: NCT07218185 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Not Yet Recruiting

Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage

Condition: Hypofibrinogenemia · Hemorrhage · Trauma Associated Hemorrhage  ·  Sponsor: Cerus Corporation

PhaseN/A
Planned participants320
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The objective of this multicenter, single-arm, observational study is to determine the feasibility and effectiveness of early administration of FDA-approved, pre-thawed Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT Fibrinogen Complex, IFC) in trauma patients with hemorrhagic shock (HS) and functional hypofibrinogenemia. This study will determine whether rapid point-of-care testing for functional hypofibrinogenemia and availability of a shelf-stable fibrinogen complex (IFC) results in shorter time to administration of fibrinogen replacement and correction of functional hypofibrinogenemia, as compared with historical controls and published literature using conventional cryoprecipitate-AHF (CRYO-AHF). This study aims to: * Demonstrate the feasibility and response to early administration of pre-thawed IFC when ordered during initial resuscitation of severely injured patients with HS and functional hypofibrinogenemia. * Assess the effectiveness of early administration of pre-thawed IFC on correction of functional hypofibrinogenemia and on proximate process measures of resuscitation, including time to hemostasis, time to completion of resuscitation, and total volume of resuscitation. * Assess clinical outcomes in severely injured patients with HS and functional hypofibrinogenemia receiving early administration of pre-thawed IFC.

This description comes directly from the study's public registry record.

Talk to the study team

Laurence Corash, MD  ·  925-288-6118  ·  lcorash@cerus.com

Always discuss trial participation with your own doctor first.

Locations (4)

Anschutz Medical Center, University of ColoradoAurora, Colorado, United States
Ryder Trauma Center/Jackson Memorial Hospital, University of MiamiMiami, Florida, United States
R Adams Cowley Shock Trauma Center, University of MarylandBaltimore, Maryland, United States
Barnes Jewish Hospital, Washington University of Saint LouisSt Louis, Missouri, United States

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →